CXCL13 and chlamydia infectious disease: Following Chlamydia infection, mast cell-deficient mice displayed attenuated CXCL2 production, with the levels of other proinflammatory mediators including CCL2, CCL5, CXCL13, and effector mediators assessed as not being significantly altered.